Institut Paoli-calmettes

This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy before surgery can improve outcomes for people with HER2-negative inflammatory breast cancer, a rare and aggressive type. About 52 adults will receive either chemo alone or chemo plus pe…

This study looks at tumor and blood samples from 115 people with a common type of advanced breast cancer (HR+/HER2-). Researchers want to find genetic clues that can predict who will benefit from a combination of hormone therapy and the targeted drug ribociclib. By comparing samp…

This study measures two proteins in the blood, MMP2 and MMP9, to see if they can predict how well certain drugs work in people with kidney cancer that has spread. Researchers will compare patients treated with anti-angiogenic drugs to those not receiving these drugs. The goal is …

This study collects tissue and blood samples from 300 women with suspected ovarian, endometrial, or cervical cancer. Researchers analyze genes and proteins to find patterns that may predict how the cancer behaves. The goal is to improve future diagnosis and treatment, not to test…